News

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in ...
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...
In mid-April 2025, social media users spread a rumor that U.S. President Donald Trump's administration would end animal ...
Behind every diagnosis, treatment, and cure, there's a team of unsung heroes working tirelessly in the laboratory. I am ...
Wyatt McDonnell of Infinimmune shares insight on human-first models and what the FDA's policy shift means for biotech R&D.
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
A small group of antibodies in your blood stays the same for years, even after vaccines. These stable antibodies create a unique and personal immune 'fingerprint' that barely changes over time. The ...
Cruelty Free International welcomes major shift towards humane, modern approaches to drug development and testing ...
More than 100 federal scientists who track bird flu, including vaccine and food safety experts, have been laid off. This comes as the deadly pathogen rips through dairy herds and poultry flocks.